Webcasted Industry Sessions

Webcasted Industry Sessions

Company Session title Session details Watch session
Biogen Amyloid related imaging abnormalities – from clinical trials to clinical practice: a practice-based discussion Click here Play here
Biogen Education Theater
The time is Now: The Importance of Early Detection and Diagnosis of Alzheimer’s Disease		 Click here Play here
Biogen Perspectives on Alzheimer’s disease: underlying pathology and its impact on people living with the disease Click here Play here
Biomax Product Theater
Better outcomes from imaging in neurodegeneration clinical trials		 Click here Play here
Cognito Therapeutics Predicting Alzheimer’s Disease Progression with Neurophysiological Markers Click here Play here
Cure Alzheimer’s Fund Brain Entry and Exit Routes for Cells and Molecules Click here Play here
Eisai Amyloid-β Pathway: Evolving Scientific Knowledge and Clinical Implications for Alzheimer’s Disease Click here Play here
GE Healthcare Diagnostic Framework for the use of PET and SPECT imaging agents in Alzheimer’s disease and other dementias Click here Play here
Green Valley Gut microbiota and Parkinson’s disease: Implications for pathogenesis and treatment Click here Play here
Grifols Novel approaches in AD: Cutting Edge Science, Diagnostic and Therapeutic Strategies Click here Play here
Lilly How can the use of Alzheimer’s Disease diagnostic biomarkers in clinical practice help identify appropriate patients for future Disease Modifying Therapy? Click here Play here
Novo Nordisk The future of AD and PD – reaching beyond symptom control Click here Play here
Roche Alzheimer’s disease – Let’s ADdress it together Click here Play here
Roche Workshop1: Where does our hope come from in Alzheimer’s disease? Click here Play here
Roche Workshop 2: Balancing innovation and access: how do we optimize a standard of care and equity in Alzheimer’s? Click here Play here
Print Friendly, PDF & Email